Style Editor Docs
     
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • Research (White Papers)
    • US FDA IDE Application
      • US FDA IDE Pre-Submission Process
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Vivos Inc.
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
   Contact Us
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • Research (White Papers)
    • US FDA IDE Application
      • US FDA IDE Pre-Submission Process
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Vivos Inc.
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
  1. Blog
Vivos February 2023 Update  | IsoPet® - RadioGel™
February 28, 2023

Vivos February 2023 Update | IsoPet® - RadioGel™

After several months of planning, preparation, and FDA review the first VX-2 tumors were injected with low-activity IsoPet® to deliver a very high 800 Gy dose. The local activity is now being measured over time using PET-CT to demonstrate that the IsoPet® will kill the VX-2 tumors and that the hydrogel effectively keeps the Yttrium-90 at the point of injection, thus limiting the migration to other areas of the body.

Read more...

Supply Chain Management | IsoPet® - RadioGel™
February 10, 2023

Supply Chain Management | IsoPet® - RadioGel™

Last year we developed two alternate suppliers for the polymer that is used to produce the hydrogel component. This year we are focusing on the more difficult task of locating a second supplier for our yttrium-90 phosphate particles.

Read more...

Vivos January Update
February 01, 2023

Vivos January Update

The first month of 2023 has come to a close, and we're pleased to share our business recap and updates for the end of January.

Read more...

Path to FDA IDE Submission
January 26, 2023

Path to FDA IDE Submission

Vivos Inc has dedicated several years to strengthening our Quality Management System (QMS). This topic is low visibility but very important behind the scenes. Any future human therapies must be vital in this area, and we anticipate strict FDA audits on all aspects of the way we conduct our business.

Read more...

Exubrion Therapeutics® and Vivos Inc collaborate on joint abstract
January 10, 2023

Exubrion Therapeutics® and Vivos Inc collaborate on joint abstract

Dr. Nigel Stevenson from Exubrion Therapeutics® and Dr. Mike Korenko have just submitted a joint abstract entitled “Precision Radionuclide Therapy for Treating Veterinary Cancerous Tumors and Osteoarthritis” to the 11th International Conference on Isotopes on July 23-24 in Saskatoon Canada.

Read more...

Vivos December Update
January 03, 2023

Vivos December Update

2022 has come to a close, and we're pleased to share our business update for the end of December.

Read more...

Dr. John E. Heidrich, PHD, VCM joins our Veterinary Medicine Advisory Board
December 29, 2022

Dr. John E. Heidrich, PHD, VCM joins our Veterinary Medicine Advisory Board

Dr. John E. Heidrich, Ph.D., VCM, joined our Veterinary Medicine Advisory Board, chaired by Dr. Alice Villalobos. He recently retired as co-owner of VCA Ventana Animal Hospital in Albuquerque, NM. He brings senior practical experience in veterinary medicine and will be particularly helpful in locating patients for IsoPet therapy. He recently accompanied us at our booth at the 68th Annual Convention of the American Association of Equine Practitioners, AAEP, in San Antonio, Texas.

Read more...

Vivos November Update
December 01, 2022

Vivos November Update

We had a booth at the 68th Annual Convention of the American Association of Equine Practitioners, AAEP in San Antonio, Texas. This is the largest equine conference of the year with 4200 people registered (1400 exhibitors, 2800 DVMs, Guests, Students, Techs).

Read more...

Vivos October Update
November 01, 2022

Vivos October Update

There are two monthly highlights of our progress. Veterinary Cancer Society Conference, and an update on our FDA Pre-Submission IDE process - Dr. Mike Korenko

Read more...

Vivos September Update
October 01, 2022

Vivos September Update

I am pleased to provide a monthly update on our progress. I am responding to the feedback that the community appreciates the press releases, but would like more frequent updates. - Dr. Mike Korenko

Read more...

Show more

Vivos, Inc.

Precision Radionuclide Therapy (PRnT)

OTCQB: RDGL

contact: info@radiogel.com


Home Page Cover Image: 

 

Veterinarian Dr. Michelle Myer from Vista Veterinarian Hospital in Kennewick, WA.

 

Seen here administering IsoPet® therapy to a feline suffering from a sarcoma.

RadioGel™ is a hydrogel liquid containing tiny yttrium-90 (90Y)  phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.

IsoPet® Therapy Application(s)


Precision Radionuclide Therapy (PRnT)


Vivos Inc.
 - (OTCQB: RDGL) Investor Relations 

Contact

 

Main colors
   bg-primary
   bg-primary-light
   bg-primary-dark
   bg-secondary
   bg-secondary-dark
Template sections
   body
   top-header
   header
   content
Footer Styles
   background
   text color
   link color
   horizontal line
Buttons
   style 1
   style 2
   style 3
Other elements
  social icons
  navigation color
  subnav background
Mobile navigation
   background color
   navigation color
Template configurations
has-right-nav g-font
navigation styles
size-15 weight-400 snip-nav
content styles
form-white
footer styles
o-form color-white
Typography
Heading H1
weight-600
Heading H2
weight-600
Heading H3
weight-600
Buttons
weight-600 is-uppercase
Animations

Note:
All changes made here will be applied to your entire website.
is-switcher admin-only

RadioGel™ Logo

Precision Radionuclide Therapy (PRnT)

draggable-logo

About | Privacy Policy | Cookie Policy | Sitemap
© 2023 Vivos Inc. | RadioGel™ is a registered trademark | IsoPet® is a registered trademark
Log out | Edit
  • Scroll to top